BIOMAT Database Logo BIOMAT Database Logo

Synthetic sorbents for removal of factor VIII inhibitors from haemophilic A plasma. 1995

L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
Laboratoire d'Hémorhéologie-Hématologie, Faculté de Médecine, Vandoeuvre lès Nancy, France.

Human factor VIII (FVIII) is a protein of the blood coagulation system that is absent or defective in patients with haemophilia A. A most serious complication following replacement therapy in 10-15% of patients treated with available FVIII concentrate is the development of inhibitors of FVIII (anti-FVIII). Some polymers functionalized with suitable chemical substituents which mimic part of the epitope of FVIII recognized by the inhibitors might be used in extracorporeal circulation to reduce the concentration of antibodies to FVIII. For this purpose, insoluble polystyrene bearing sulfonate and L-tyrosine methyl ester sulfamide groups have been synthesized. The in vitro removal of anti-FVIII inhibitors from plasmas of patients with haemophilia A was performed. Different chromatographic parameters were studied and optimized.

UI MeSH Term Description Entries
D011137 Polystyrenes Polymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads. Polystyrol,Polystyrene,Polystyrols
D012117 Resins, Synthetic Polymers of high molecular weight which at some stage are capable of being molded and then harden to form useful components. Dental Resins,Dental Resin,Resin, Dental,Resin, Synthetic,Resins, Dental,Synthetic Resin,Synthetic Resins
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000327 Adsorption The adhesion of gases, liquids, or dissolved solids onto a surface. It includes adsorptive phenomena of bacteria and viruses onto surfaces as well. ABSORPTION into the substance may follow but not necessarily. Adsorptions

Related Publications

L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
Distinguishing lupus anticoagulants from factor VIII inhibitors in haemophilic and non-haemophilic patients.
September 2018, Haemophilia : the official journal of the World Federation of Hemophilia,
L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
Grafted synthetic sorbents for enhanced removal of toxic chemical agents from plasma.
November 1983, Journal of biomedical materials research,
L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
An artificial 'haemophilic' plasma for one-stage factor-VIII assay.
November 1978, British journal of haematology,
L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
Dilution of haemophilic plasma used as a reagent in the determination of anti-haemophilic factor A (factor VIII).
January 1974, Haemostasis,
L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
Traumatic rupture of the liver in a haemophilic patient with factor-VIII inhibitors.
June 1976, Lancet (London, England),
L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
Immunological studies of anti-haemophilic factor a (factor VIII).
January 1973, The Netherlands journal of medicine,
L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
The corrective effect of Factor VIII-coated red blood cells in haemophilic plasma with antibodies to Factor VIII.
March 1974, Thrombosis et diathesis haemorrhagica,
L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
Extracorporeal immunoadsorption for the treatment of haemophilic patients with inhibitors to factor VIII or IX.
January 1999, Vox sanguinis,
L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
November 2004, Haemophilia : the official journal of the World Federation of Hemophilia,
L Dahri, and C Boisson-Vidal, and V Regnault, and D Muller, and Y Sultan, and J F Stolz
Factor VIII in blood plasma of haemophilic sheep: analysis of clotting time-plasma dilution curves.
January 1994, Haemostasis,
Copied contents to your clipboard!